GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,775.00p
   
  • Change Today:
    -8.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,316.00p
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 9,685,447
  • Market Cap: £73,572m
  • RiskGrade: 129

GSK Q1 beats estimates

By Frank Prenesti

Date: Wednesday 26 Apr 2023

LONDON (ShareCast) - (Sharecast News) - GSK first quarter profits and revenue both beat expectations driven by its shingles and meningitis treatments, among others.
The company posted revenue of £7bn against expectations of £6.5bnm according to company-compiled estimates. Adjusted operating profit rose 8% to £2.1bn as GSK also maintained full-year guidance.

Its shingles vaccine, Shingrix, generated sales of £833m, beating estimates of £829m.

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,775.00p
Change Today -8.50p
% Change -0.48 %
52 Week High 1,812.50p
52 Week Low 1,316.00p
Volume 9,685,447
Shares Issued 4,144.92m
Market Cap £73,572m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.05% below the market average69.05% below the market average69.05% below the market average69.05% below the market average69.05% below the market average
45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average
Price Trend
47.89% above the market average47.89% above the market average47.89% above the market average47.89% above the market average47.89% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average
Income
2.90% above the market average2.90% above the market average2.90% above the market average2.90% above the market average2.90% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
20.71% below the market average20.71% below the market average20.71% below the market average20.71% below the market average20.71% below the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 17-May-2024

Time Volume / Share Price
16:51 423 @ 1,775.00p
16:37 20,200 @ 1,771.97p
16:36 10,580 @ 1,775.00p
16:35 3,357,820 @ 1,775.00p
16:35 2,092 @ 1,775.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page